INNOVATIVE EYEWEAR, INC. (LUCY) Current Ratio
- Current ratio · latest quarter: Value 12.06×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 12.06× | Current assets / current liabilities. $6.79M ÷ $562.73K ≈ 12.06× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 6.79M USD | Assets, Current |
| Current obligations | 562.73K USD | Liabilities, Current |
| Cash and equivalents | 2.46M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 136.40K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 1.77M USD | Inventory, Net |
| Payables | (m) | |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.79M | $562.73K | $2.46M | (m) | $136.40K | $1.77M | (m) | (m) | 12.06× |
| 2026-03-31 | $8.75M | $1.09M | $4.38M | (m) | $71.51K | $1.40M | (m) | (m) | 8.02× |
| 2025-12-31 | $9.44M | $1.05M | $6.51M | (m) | $142.15K | $1.75M | (m) | (m) | 9.03× |
| 2025-09-30 | $10.60M | $884.65K | $6.70M | (m) | $83.36K | $1.63M | (m) | (m) | 11.98× |
| 2025-06-30 | $11.33M | $606.06K | $7.63M | (m) | $57.96K | $1.68M | (m) | (m) | 18.70× |
| 2025-03-31 | $7.33M | $447.24K | $5.26M | (m) | $89.66K | $1.13M | (m) | (m) | 16.39× |
| 2024-12-31 | $9.24M | $737.72K | $2.63M | (m) | $107.92K | $831.76K | (m) | (m) | 12.52× |
| 2024-09-30 | $10.99M | $652.96K | $4.54M | (m) | $80.89K | $915.18K | (m) | (m) | 16.83× |
| 2024-06-30 | $7.29M | $494.63K | $5.90M | (m) | $61.61K | $930.49K | (m) | (m) | 14.73× |
| 2024-03-31 | $4.11M | $883.49K | $2.65M | (m) | $52.78K | $858.90K | (m) | (m) | 4.65× |
| 2023-12-31 | $5.62M | $624.49K | $4.29M | (m) | $93.21K | $533.24K | (m) | (m) | 8.99× |
| 2023-09-30 | $7.50M | $431.18K | $3.90M | (m) | $127.62K | $776.14K | (m) | (m) | 17.40× |
| 2023-06-30 | $8.77M | $330.59K | $5.36M | (m) | $130.66K | $659.87K | (m) | (m) | 26.53× |
| 2023-03-31 | $4.54M | $504.65K | $3.45M | (m) | $127.64K | $743.08K | (m) | (m) | 9.00× |
| 2022-12-31 | $4.24M | $600.00K | $3.59M | (m) | $110.26K | $94.70K | (m) | (m) | 7.07× |
| 2022-09-30 | $6.10M | $851.05K | $4.98M | (m) | $187.59K | $422.90K | (m) | (m) | 7.17× |
| 2022-06-30 | $835.47K | $2.45M | $34.88K | (m) | $186.88K | $325.41K | (m) | (m) | 0.34× |
| 2021-12-31 | $644.33K | $616.80K | $79.73K | (m) | $43.39K | $275.50K | (m) | (m) | 1.04× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RxSight, Inc. (RXST) | United States | $0.197B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |